首页 > 最新文献

Rare Tumors最新文献

英文 中文
Treatment outcomes of adjuvant radiotherapy in adrenocortical carcinoma - A 13-years experience from a tertiary care centre. 辅助放射治疗肾上腺皮质癌的治疗结果-三级护理中心13年的经验。
IF 0.9 Q4 Medicine Pub Date : 2023-01-01 DOI: 10.1177/20363613231160699
Divya Khosla, Rakesh Kapoor, Aditya K Singla, Kannan Periasamy, Shikha Goyal, Renu Madan, Narendra Kumar, Arunanshu Behera, Shrawan K Singh, Sanjay K Bhadada, Rama Walia

Purpose: Adrenocortical carcinoma (ACC) is a rare and highly aggressive malignant neoplasm, usually diagnosed in advanced stage. Role and efficacy of adjuvant radiotherapy has not been well defined. The objective of this study is to describe the various clinical characteristics and prognostic factors affecting the survival of ACC along with the role radiotherapy on overall survival and relapse free survival.

Methods: A retrospective analysis of 30 patients registered between 2007 and 2019 was carried out. The medical records containing clinical and treatment details were analysed. Data was analysed using SPSS 25.0. Survival curves were computed using Kaplan-Meier method. Univariate and multivariate analyses were performed to analyze the prognostic factors affecting the outcome. A p value of less than 0.05 was considered to be statistically significant.

Results: The median age of patients was 37.5 years (range, 5-72 years). 20 patients were females. Twenty-six patients had advanced stage (III/IV) disease while only four patients presented in early stage. Twenty-six patients underwent total adrenalectomy. Eighty three percent patients received adjuvant radiation therapy. The median follow up was 35.5 months (range, 7 monthss-132months). The estimated three- and 5-years overall survival (OS) was 67.2% and 23.3%, respectively. Capsular invasion and positive margins were the independent prognostic factors influencing both OS and relapse free survival (RFS). Out of 25 patients who received adjuvant radiation, only three patients had local relapse.

Conclusion: ACC is a rare and aggressive neoplasm with majority of patients presenting in advanced stage. Surgical resection with negative margins remains the mainstay of treatment. Capsular invasion and positive margins are independent prognostic factors for survival. Adjuvant radiation reduces the risk of local relapse and is well tolerated. Radiation can be used effectively in adjuvant and palliative settings in ACC.

目的:肾上腺皮质癌(ACC)是一种罕见的高侵袭性恶性肿瘤,通常在晚期诊断。辅助放疗的作用和疗效尚未明确。本研究的目的是描述影响ACC生存的各种临床特征和预后因素,以及放疗对总生存和无复发生存的作用。方法:对2007 - 2019年登记的30例患者进行回顾性分析。对包含临床和治疗细节的病历进行分析。数据采用SPSS 25.0进行分析。生存曲线采用Kaplan-Meier法计算。进行单因素和多因素分析,分析影响预后的因素。p值小于0.05认为有统计学意义。结果:患者中位年龄为37.5岁(范围5-72岁)。女性20例。26例为晚期(III/IV),仅有4例为早期。26例患者行全肾上腺切除术。83%的患者接受了辅助放射治疗。中位随访时间为35.5个月(范围7 -132个月)。估计3年和5年总生存率(OS)分别为67.2%和23.3%。囊膜浸润和阳性切缘是影响OS和无复发生存期(RFS)的独立预后因素。在接受辅助放疗的25例患者中,只有3例患者局部复发。结论:ACC是一种罕见的侵袭性肿瘤,以晚期肿瘤居多。手术切除阴性切缘仍然是主要的治疗方法。囊膜浸润和阳性切缘是独立的预后因素。辅助放疗降低了局部复发的风险,并且耐受性良好。在ACC的辅助治疗和姑息治疗中,放疗可以有效地应用。
{"title":"Treatment outcomes of adjuvant radiotherapy in adrenocortical carcinoma - A 13-years experience from a tertiary care centre.","authors":"Divya Khosla,&nbsp;Rakesh Kapoor,&nbsp;Aditya K Singla,&nbsp;Kannan Periasamy,&nbsp;Shikha Goyal,&nbsp;Renu Madan,&nbsp;Narendra Kumar,&nbsp;Arunanshu Behera,&nbsp;Shrawan K Singh,&nbsp;Sanjay K Bhadada,&nbsp;Rama Walia","doi":"10.1177/20363613231160699","DOIUrl":"https://doi.org/10.1177/20363613231160699","url":null,"abstract":"<p><strong>Purpose: </strong>Adrenocortical carcinoma (ACC) is a rare and highly aggressive malignant neoplasm, usually diagnosed in advanced stage. Role and efficacy of adjuvant radiotherapy has not been well defined. The objective of this study is to describe the various clinical characteristics and prognostic factors affecting the survival of ACC along with the role radiotherapy on overall survival and relapse free survival.</p><p><strong>Methods: </strong>A retrospective analysis of 30 patients registered between 2007 and 2019 was carried out. The medical records containing clinical and treatment details were analysed. Data was analysed using SPSS 25.0. Survival curves were computed using Kaplan-Meier method. Univariate and multivariate analyses were performed to analyze the prognostic factors affecting the outcome. A <i>p</i> value of less than 0.05 was considered to be statistically significant.</p><p><strong>Results: </strong>The median age of patients was 37.5 years (range, 5-72 years). 20 patients were females. Twenty-six patients had advanced stage (III/IV) disease while only four patients presented in early stage. Twenty-six patients underwent total adrenalectomy. Eighty three percent patients received adjuvant radiation therapy. The median follow up was 35.5 months (range, 7 monthss-132months). The estimated three- and 5-years overall survival (OS) was 67.2% and 23.3%, respectively. Capsular invasion and positive margins were the independent prognostic factors influencing both OS and relapse free survival (RFS). Out of 25 patients who received adjuvant radiation, only three patients had local relapse.</p><p><strong>Conclusion: </strong>ACC is a rare and aggressive neoplasm with majority of patients presenting in advanced stage. Surgical resection with negative margins remains the mainstay of treatment. Capsular invasion and positive margins are independent prognostic factors for survival. Adjuvant radiation reduces the risk of local relapse and is well tolerated. Radiation can be used effectively in adjuvant and palliative settings in ACC.</p>","PeriodicalId":46078,"journal":{"name":"Rare Tumors","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/fc/21/10.1177_20363613231160699.PMC9969472.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10824322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Epcoritamab-bysp (Epkinly) - A phenomenal breakthrough in the treatment of diffuse large B-cell lymphoma. Epkinly - Epcoritamab-bysp -弥漫性大b细胞淋巴瘤治疗的显著突破。
IF 0.9 Q4 Medicine Pub Date : 2023-01-01 DOI: 10.1177/20363613231193566
Rumaisa Riaz, Afsheen Khan, Tasmiyah Siddiqui
The most prevalent non-Hodgkin lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), affects 25,000 people annually and accounts for roughly 30% of cases of Non-Hodgkin Lymphoma. 1 Rituximab and chemotherapy are commonly used in the treatment of diffuse large B-cell lymphoma (DLBCL) to cure the patient; however, a signi fi cant portion of patients, up to 40%, are bound to experience relapsed or refractory disease. In such cases, salvage chemotherapy followed by autologous stem cell transplantation is the standard approach, but less than half of the patients achieve long-term disease control. 2 Those who face refractory disease or experience relapse after transplantation have limited treatment options and generally have poor overall survival rates. 2,3 To address this unmet medical need, the Food and Drug Administration (FDA) has recently given Epcoritamab-bysp (Epkinly, Genmab US, Inc.) accelerated approval for the treatment of relapsed or refractory DLBCL, including cases where DLBCL arises from indolent lymphoma or high-grade B-cell lymphoma after two or more lines of systemic therapy. This approval signi fi es an important advancement, providing a potential therapeutic option for patients who have exhausted standard treatments. 4
{"title":"Epcoritamab-bysp (Epkinly) - A phenomenal breakthrough in the treatment of diffuse large B-cell lymphoma.","authors":"Rumaisa Riaz,&nbsp;Afsheen Khan,&nbsp;Tasmiyah Siddiqui","doi":"10.1177/20363613231193566","DOIUrl":"https://doi.org/10.1177/20363613231193566","url":null,"abstract":"The most prevalent non-Hodgkin lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), affects 25,000 people annually and accounts for roughly 30% of cases of Non-Hodgkin Lymphoma. 1 Rituximab and chemotherapy are commonly used in the treatment of diffuse large B-cell lymphoma (DLBCL) to cure the patient; however, a signi fi cant portion of patients, up to 40%, are bound to experience relapsed or refractory disease. In such cases, salvage chemotherapy followed by autologous stem cell transplantation is the standard approach, but less than half of the patients achieve long-term disease control. 2 Those who face refractory disease or experience relapse after transplantation have limited treatment options and generally have poor overall survival rates. 2,3 To address this unmet medical need, the Food and Drug Administration (FDA) has recently given Epcoritamab-bysp (Epkinly, Genmab US, Inc.) accelerated approval for the treatment of relapsed or refractory DLBCL, including cases where DLBCL arises from indolent lymphoma or high-grade B-cell lymphoma after two or more lines of systemic therapy. This approval signi fi es an important advancement, providing a potential therapeutic option for patients who have exhausted standard treatments. 4","PeriodicalId":46078,"journal":{"name":"Rare Tumors","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/66/f3/10.1177_20363613231193566.PMC10392166.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10301535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Primary tracheal obstruction caused by adenoid cystic carcinoma during pregnancy: A case report. 妊娠期腺样囊性癌致原发性气管梗阻1例。
IF 0.9 Q4 Medicine Pub Date : 2022-11-01 eCollection Date: 2022-01-01 DOI: 10.1177/20363613221135015
Yongguo Xie, Ke Qin, Xueke Du, Shaopeng Ming, Lianmei Li, Chuangsheng Huang

The incidence of malignant tumors diagnosed during pregnancy is increasing, often ascribed to the recently recognized trend that many women are postponing childbirth. Although early diagnosis is optimal for both mothers and fetuses, the diagnosis of malignant tumors during pregnancy is often delayed until an advanced stage, because generalized symptoms of pregnancy and malignancy may overlap, such as shortness of breath, chest or abdominal discomfort. The study patient was 21 years old, and 31 weeks-pregnant when she was diagnosed with primary tracheal adenoid cystic carcinoma (ACC). The patient initially presented with dyspnea and decreased blood oxygen saturation and underwent a cesarean section on the first night of hospitalization, resulting from fetal distress. This case report intended to investigate potential barriers to the timely diagnosis of tracheal ACC and consider optimal management strategies when it is diagnosed during pregnancy.

怀孕期间诊断出的恶性肿瘤的发病率正在增加,这通常归因于最近认识到的许多妇女推迟分娩的趋势。虽然早期诊断对母亲和胎儿都是最佳的,但怀孕期间恶性肿瘤的诊断往往延迟到晚期,因为妊娠和恶性肿瘤的全身性症状可能重叠,如呼吸短促、胸部或腹部不适。该研究患者21岁,怀孕31周时被诊断为原发性气管腺样囊性癌(ACC)。患者最初表现为呼吸困难和血氧饱和度降低,住院第一晚因胎儿窘迫行剖宫产手术。本病例报告旨在探讨及时诊断气管ACC的潜在障碍,并考虑妊娠期诊断时的最佳管理策略。
{"title":"Primary tracheal obstruction caused by adenoid cystic carcinoma during pregnancy: A case report.","authors":"Yongguo Xie,&nbsp;Ke Qin,&nbsp;Xueke Du,&nbsp;Shaopeng Ming,&nbsp;Lianmei Li,&nbsp;Chuangsheng Huang","doi":"10.1177/20363613221135015","DOIUrl":"https://doi.org/10.1177/20363613221135015","url":null,"abstract":"<p><p>The incidence of malignant tumors diagnosed during pregnancy is increasing, often ascribed to the recently recognized trend that many women are postponing childbirth. Although early diagnosis is optimal for both mothers and fetuses, the diagnosis of malignant tumors during pregnancy is often delayed until an advanced stage, because generalized symptoms of pregnancy and malignancy may overlap, such as shortness of breath, chest or abdominal discomfort. The study patient was 21 years old, and 31 weeks-pregnant when she was diagnosed with primary tracheal adenoid cystic carcinoma (ACC). The patient initially presented with dyspnea and decreased blood oxygen saturation and underwent a cesarean section on the first night of hospitalization, resulting from fetal distress. This case report intended to investigate potential barriers to the timely diagnosis of tracheal ACC and consider optimal management strategies when it is diagnosed during pregnancy.</p>","PeriodicalId":46078,"journal":{"name":"Rare Tumors","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4c/9b/10.1177_20363613221135015.PMC9629539.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40685690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reconstruction options in recurrent dermatofibrosarcoma protuberans:A scoping review. 复发性隆突性皮肤纤维肉瘤的重建选择:范围综述。
IF 0.9 Q4 Medicine Pub Date : 2022-11-01 eCollection Date: 2022-01-01 DOI: 10.1177/20363613221123951
Vishal Mago, Arush Pasricha

Background: This review will outline the evaluation, diagnosis, and management of dermatofibrosarcoma protuberans and emphasizes multidisciplinary role of nurses, plastic surgeons and radiation oncologist in this recurrent metastatic lesion. It pinpoints affected population at risk, clinical features, and reconstruction options. No analytical research has been done in this area.

Material and methods: A scoping review of patients of DFSP who underwent reconstruction after excision of tumors was performed in the Department of Burn and Plastic Surgery, AIIMS Rishikesh. It used a five framework approach. A review of 85 similar cases reported in the literature have been scrutinized in relation to the reconstruction options, sites of the tumor, margins of excision and recurrence.

Results: 85 full length English studies were included out of the 445 cases found in Pubmed and related search engines to reveal various reconstructive options in reconstruction of DFSP defects. Present scoping review identifies free anterolateral thigh flap to be useful in 7 review articles followed by propeller flaps in 3 isolated case reports. 2 cases of free latissimus dorsi flap were used for reconstruction of abdominal defects.

Conclusion: All patients should undergo a strict screening protocol where the health personnel can play a crucial role by educating parents on the follow up and report new lesions as early as possible. All operated tumor patients can be given safety tips and education on care and risks after reconstruction with skin flaps or skin grafting. A multidisciplinary approach between the surgeon, nurse and radiation oncologist is needed for effective management of these lesions.

背景:本文将概述隆突性皮肤纤维肉瘤的评估、诊断和治疗,并强调护士、整形外科医生和放射肿瘤学家在这种复发转移性病变中的多学科作用。它确定了受影响的高危人群、临床特征和重建选择。在这方面还没有做过分析研究。材料和方法:在AIIMS Rishikesh烧伤与整形外科对肿瘤切除后重建的DFSP患者进行了范围审查。它使用了五个框架方法。本文回顾了85例文献报道的类似病例,详细分析了重建选择、肿瘤位置、切除边缘和复发的关系。结果:在Pubmed及相关搜索引擎中检索到的445例病例中,共纳入85篇完整的英文研究,揭示了DFSP缺损重建的各种重建选择。目前的范围审查确定游离大腿前外侧皮瓣是有用的7篇综述文章,其次是螺旋桨皮瓣在3个孤立的病例报告。应用游离背阔肌皮瓣修复腹部缺损2例。结论:所有患者都应接受严格的筛查方案,其中卫生人员可以通过教育家长随访和尽早报告新病变发挥关键作用。所有手术后的肿瘤患者都可以接受安全提示,以及皮瓣或植皮重建后的护理和风险教育。外科医生,护士和放射肿瘤学家之间的多学科方法需要有效地管理这些病变。
{"title":"Reconstruction options in recurrent dermatofibrosarcoma protuberans:A scoping review.","authors":"Vishal Mago,&nbsp;Arush Pasricha","doi":"10.1177/20363613221123951","DOIUrl":"https://doi.org/10.1177/20363613221123951","url":null,"abstract":"<p><strong>Background: </strong>This review will outline the evaluation, diagnosis, and management of dermatofibrosarcoma protuberans and emphasizes multidisciplinary role of nurses, plastic surgeons and radiation oncologist in this recurrent metastatic lesion. It pinpoints affected population at risk, clinical features, and reconstruction options. No analytical research has been done in this area.</p><p><strong>Material and methods: </strong>A scoping review of patients of DFSP who underwent reconstruction after excision of tumors was performed in the Department of Burn and Plastic Surgery, AIIMS Rishikesh. It used a five framework approach. A review of 85 similar cases reported in the literature have been scrutinized in relation to the reconstruction options, sites of the tumor, margins of excision and recurrence.</p><p><strong>Results: </strong>85 full length English studies were included out of the 445 cases found in Pubmed and related search engines to reveal various reconstructive options in reconstruction of DFSP defects. Present scoping review identifies free anterolateral thigh flap to be useful in 7 review articles followed by propeller flaps in 3 isolated case reports. 2 cases of free latissimus dorsi flap were used for reconstruction of abdominal defects.</p><p><strong>Conclusion: </strong><i>All patients should undergo a strict screening protocol where the health personnel can play a crucial role by educating parents on the follow up and report new lesions as early as possible. All operated tumor patients can be given safety tips and education on care and risks after reconstruction with skin flaps or skin grafting</i>. A multidisciplinary approach between the surgeon, nurse and radiation oncologist is needed for effective management of these lesions.</p>","PeriodicalId":46078,"journal":{"name":"Rare Tumors","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/dd/11/10.1177_20363613221123951.PMC9630893.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40685689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spontaneous regression of an orbital Langerhans cell histiocytosis after biopsy: A case report. Spontaneous regression of an orbital Langerhans cell histiocytosis. 眼眶朗格汉斯细胞组织细胞增多症活检后自发性消退1例报告。眼眶朗格汉斯细胞组织细胞增多症的自发消退。
IF 0.9 Q4 Medicine Pub Date : 2022-10-18 eCollection Date: 2022-01-01 DOI: 10.1177/20363613221135987
Safia Yahiaoui, Asma Ghorbel, Khadija Ben Zid, Semia Zarraa, Lina Kchaou, FidaNoubigh, Wael Kaabia, Fadoua Bouguerra, Alia Mousli, Rim Abidi, Amani Yousfi, Boujelbene Nadia, Chiraz Nasr

Langerhans histiocytosis or Langerhans cell histiocytosis (LCH) is a rare benign pathology representing less than 1% of orbital tumors. It can cause either localized or generalized lesions, leading to the destruction of hard and soft tissues. Eosinophilic granuloma is the most benign form and the predominant clinical presentation of LCH. We report a case of eosinophilic granuloma with orbital involvement in an 18-year-old male patient. Orbital radiotherapy was initially planned, but finally it was not performed due to a spontaneous regression of the lesion after the incisional biopsy. The presented case supports an expectant attitude given the possibility of a spontaneous regression after the biopsy, especially in small lesions. However, long-term follow-up is essential given the risk of recurrence.

朗格汉斯组织细胞增生症(LCH)是一种罕见的良性病理,占眼眶肿瘤的不到1%。它可以引起局部或全身性病变,导致硬组织和软组织的破坏。嗜酸性肉芽肿是LCH最良性的形式和主要的临床表现。我们报告一个18岁男性患者眼眶受累的嗜酸性肉芽肿病例。最初计划眼眶放射治疗,但最终因切口活检后病变自发消退而未进行。鉴于活检后自发消退的可能性,特别是在小病变中,所提出的病例支持期待的态度。然而,考虑到复发的风险,长期随访是必要的。
{"title":"Spontaneous regression of an orbital Langerhans cell histiocytosis after biopsy: A case report. Spontaneous regression of an orbital Langerhans cell histiocytosis.","authors":"Safia Yahiaoui,&nbsp;Asma Ghorbel,&nbsp;Khadija Ben Zid,&nbsp;Semia Zarraa,&nbsp;Lina Kchaou,&nbsp;FidaNoubigh,&nbsp;Wael Kaabia,&nbsp;Fadoua Bouguerra,&nbsp;Alia Mousli,&nbsp;Rim Abidi,&nbsp;Amani Yousfi,&nbsp;Boujelbene Nadia,&nbsp;Chiraz Nasr","doi":"10.1177/20363613221135987","DOIUrl":"https://doi.org/10.1177/20363613221135987","url":null,"abstract":"<p><p>Langerhans histiocytosis or Langerhans cell histiocytosis (LCH) is a rare benign pathology representing less than 1% of orbital tumors. It can cause either localized or generalized lesions, leading to the destruction of hard and soft tissues. Eosinophilic granuloma is the most benign form and the predominant clinical presentation of LCH. We report a case of eosinophilic granuloma with orbital involvement in an 18-year-old male patient. Orbital radiotherapy was initially planned, but finally it was not performed due to a spontaneous regression of the lesion after the incisional biopsy. The presented case supports an expectant attitude given the possibility of a spontaneous regression after the biopsy, especially in small lesions. However, long-term follow-up is essential given the risk of recurrence.</p>","PeriodicalId":46078,"journal":{"name":"Rare Tumors","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2022-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/28/56/10.1177_20363613221135987.PMC9583201.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40567276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case of initially metastasizing pleomorphic adenoma of parotid gland. 腮腺多形性腺瘤初转移1例。
IF 0.9 Q4 Medicine Pub Date : 2022-10-03 eCollection Date: 2022-01-01 DOI: 10.1177/20363613221130155
Sungchul Ko, Kye Hoon Park, Ji-Hye Lee, Ki Nam Park

Metastasis of pleomorphic adenoma (PA) is rare and usually presented as a locoregional recurrence developed many years after excision of the primary tumor although the PA is the most common neoplasm in the parotid gland. We described a case of a 48-year-old male with a parotid tumor with multiple enlarged ipsilateral lymph nodes which suggested a malignancy. The tumors had been neither evaluated nor excised and preoperative evaluation revealed benign PA in both lesions. After the complete surgical excision, the final pathology was notable for benign PA with metastasis to regional lymph nodes. At 1 year follow up he was clinically and radiographically free of disease. This implies that pleomorphic adenoma can occur as initially metastasis to regional lymph node even though benign neoplasm.

多形性腺瘤(PA)是腮腺中最常见的肿瘤,但它的转移是罕见的,通常表现为原发肿瘤切除多年后的局部复发。我们描述了一个病例48岁的男性腮腺肿瘤与多个扩大的同侧淋巴结提示恶性肿瘤。肿瘤既没有评估也没有切除,术前评估显示两个病变均为良性PA。完全手术切除后,良性PA转移到区域淋巴结的最终病理是显著的。在1年的随访中,他的临床和放射学无疾病。这表明多形性腺瘤即使是良性肿瘤,也可以在最初转移到区域淋巴结时发生。
{"title":"A case of initially metastasizing pleomorphic adenoma of parotid gland.","authors":"Sungchul Ko,&nbsp;Kye Hoon Park,&nbsp;Ji-Hye Lee,&nbsp;Ki Nam Park","doi":"10.1177/20363613221130155","DOIUrl":"https://doi.org/10.1177/20363613221130155","url":null,"abstract":"<p><p>Metastasis of pleomorphic adenoma (PA) is rare and usually presented as a locoregional recurrence developed many years after excision of the primary tumor although the PA is the most common neoplasm in the parotid gland. We described a case of a 48-year-old male with a parotid tumor with multiple enlarged ipsilateral lymph nodes which suggested a malignancy. The tumors had been neither evaluated nor excised and preoperative evaluation revealed benign PA in both lesions. After the complete surgical excision, the final pathology was notable for benign PA with metastasis to regional lymph nodes. At 1 year follow up he was clinically and radiographically free of disease. This implies that pleomorphic adenoma can occur as initially metastasis to regional lymph node even though benign neoplasm.</p>","PeriodicalId":46078,"journal":{"name":"Rare Tumors","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2022-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/50/bd/10.1177_20363613221130155.PMC9536096.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33496269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Very low-dose radiation therapy for management of inflammatory myofibroblastic tumor of the lung. 极低剂量放疗治疗肺炎性肌成纤维细胞瘤。
IF 0.9 Q4 Medicine Pub Date : 2022-07-15 eCollection Date: 2022-01-01 DOI: 10.1177/20363613221106270
Nimeh Najjar, Hamel Patel, Scott Steinberg, Brett Baskovich, Stephanie Rothweiler, Bradford Hoppe

Inflammatory myofibroblastic tumor (IMT) is an uncommon chest pathology. Treatment primarily focuses on surgical resection for diagnostic and therapeutic purposes. However, there are instances in which alternative therapies with steroids, chemotherapy, or radiation are necessary. We discuss a case of recurrent IMT for which very low dose radiation proved an effective treatment.

炎症性肌纤维母细胞瘤(IMT)是一种罕见的胸部病理。治疗主要集中在手术切除诊断和治疗目的。然而,在某些情况下,类固醇、化疗或放疗等替代疗法是必要的。我们讨论了一例复发性IMT,非常低剂量的辐射证明是有效的治疗。
{"title":"Very low-dose radiation therapy for management of inflammatory myofibroblastic tumor of the lung.","authors":"Nimeh Najjar,&nbsp;Hamel Patel,&nbsp;Scott Steinberg,&nbsp;Brett Baskovich,&nbsp;Stephanie Rothweiler,&nbsp;Bradford Hoppe","doi":"10.1177/20363613221106270","DOIUrl":"https://doi.org/10.1177/20363613221106270","url":null,"abstract":"<p><p>Inflammatory myofibroblastic tumor (IMT) is an uncommon chest pathology. Treatment primarily focuses on surgical resection for diagnostic and therapeutic purposes. However, there are instances in which alternative therapies with steroids, chemotherapy, or radiation are necessary. We discuss a case of recurrent IMT for which very low dose radiation proved an effective treatment.</p>","PeriodicalId":46078,"journal":{"name":"Rare Tumors","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2022-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/24/a4/10.1177_20363613221106270.PMC9290091.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40610937","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Supratentorial cortical ependymoma: A systematic literature review and case illustration. 幕上皮质室管膜瘤:系统的文献回顾和病例说明。
IF 0.9 Q4 Medicine Pub Date : 2022-07-08 eCollection Date: 2022-01-01 DOI: 10.1177/20363613221112432
Joshua A Cuoco, Andrew C Strohman, Brittany M Stopa, Michael S Stump, John J Entwistle, Mark R Witcher, Adeolu L Olasunkanmi

Cortical ependymomas are currently not considered a subgroup of supratentorial ependymomas; however, there is a growing body of literature investigating the natural history of these lesions compared to supratentorial ependymomas. We performed a systematic literature review of cortical ependymomas with a focus on the natural history, clinical characteristics, and clinical outcomes of these lesions as compared to supratentorial ependymomas. Our search revealed 153 unique cases of cortical ependymomas. The mean age on presentation was 21.2 years. Males and females comprised 58.8% (90/153) and 41.2% (63/153) of cases, respectively. The most common presenting symptom was seizure activity occurring in 44.4% of the cohort (68/153). The recently recognized C11orf95-RELA fusion was identified in 13.7% of the cohort (21/153) and 95.5% of cases (21/22) reporting molecular characterization. World Health Organization grades 2 and 3 were reported in 52.3% (79/151) and 47.7% (72/151) of cases, respectively. The frontal lobe was involved in the majority of cases (54.9%, 84/153). Gross total resection was achieved in 80.4% of cases (123/153). Tumor recurrence was identified in 27.7% of cases (39/141). Mean clinical follow-up was 41.3 months. Mean overall survival of patients who expired was 27.4 months whereas mean progression-free survival was 15.0 months. Comparatively, cortical ependymomas with C11orf95-RELA fusions and supratentorial ependymomas with C11orf95 RELA fusions exhibited differing clinical outcomes. Further studies with larger sample sizes are necessary to investigate the significance of RELA fusions on survival in cortical ependymomas and to determine whether cortical ependymomas with C11orf95-RELA fusions should be classified as a distinct entity.

皮质室管膜瘤目前不被认为是幕上室管膜瘤的一个亚组;然而,与幕上室管膜瘤相比,越来越多的文献研究了这些病变的自然历史。我们对皮质室管膜瘤进行了系统的文献回顾,重点是与幕上室管膜瘤相比,皮质室管膜瘤的自然史、临床特征和临床结果。我们的研究发现了153例独特的皮质室管膜瘤。平均发病年龄为21.2岁。男性占58.8%(90/153),女性占41.2%(63/153)。最常见的症状是发作活动,发生率为44.4%(68/153)。最近确认的C11orf95-RELA融合在13.7%的队列(21/153)中被确定,95.5%的病例(21/22)报告了分子特征。世界卫生组织2级和3级分别占52.3%(79/151)和47.7%(72/151)。大多数病例累及额叶(54.9%,84/153)。总切除率为80.4%(123/153)。肿瘤复发率为27.7%(39/141)。平均临床随访41.3个月。过期患者的平均总生存期为27.4个月,而平均无进展生存期为15.0个月。相比之下,C11orf95-RELA融合的皮质室管膜瘤和C11orf95-RELA融合的幕上室管膜瘤表现出不同的临床结果。为了进一步研究RELA融合对皮质室管膜瘤存活的意义,并确定是否应将具有C11orf95-RELA融合的皮质室管膜瘤作为一个独立的实体进行分类,还需要更大样本量的进一步研究。
{"title":"Supratentorial cortical ependymoma: A systematic literature review and case illustration.","authors":"Joshua A Cuoco,&nbsp;Andrew C Strohman,&nbsp;Brittany M Stopa,&nbsp;Michael S Stump,&nbsp;John J Entwistle,&nbsp;Mark R Witcher,&nbsp;Adeolu L Olasunkanmi","doi":"10.1177/20363613221112432","DOIUrl":"https://doi.org/10.1177/20363613221112432","url":null,"abstract":"<p><p>Cortical ependymomas are currently not considered a subgroup of supratentorial ependymomas; however, there is a growing body of literature investigating the natural history of these lesions compared to supratentorial ependymomas. We performed a systematic literature review of cortical ependymomas with a focus on the natural history, clinical characteristics, and clinical outcomes of these lesions as compared to supratentorial ependymomas. Our search revealed 153 unique cases of cortical ependymomas. The mean age on presentation was 21.2 years. Males and females comprised 58.8% (90/153) and 41.2% (63/153) of cases, respectively. The most common presenting symptom was seizure activity occurring in 44.4% of the cohort (68/153). The recently recognized <i>C11orf95-RELA</i> fusion was identified in 13.7% of the cohort (21/153) and 95.5% of cases (21/22) reporting molecular characterization. World Health Organization grades 2 and 3 were reported in 52.3% (79/151) and 47.7% (72/151) of cases, respectively. The frontal lobe was involved in the majority of cases (54.9%, 84/153). Gross total resection was achieved in 80.4% of cases (123/153). Tumor recurrence was identified in 27.7% of cases (39/141). Mean clinical follow-up was 41.3 months. Mean overall survival of patients who expired was 27.4 months whereas mean progression-free survival was 15.0 months. Comparatively, cortical ependymomas with <i>C11orf95</i>-<i>RELA</i> fusions and supratentorial ependymomas with <i>C11orf95 RELA</i> fusions exhibited differing clinical outcomes. Further studies with larger sample sizes are necessary to investigate the significance of <i>RELA</i> fusions on survival in cortical ependymomas and to determine whether cortical ependymomas with <i>C11orf95</i>-<i>RELA</i> fusions should be classified as a distinct entity.</p>","PeriodicalId":46078,"journal":{"name":"Rare Tumors","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2022-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/bd/87/10.1177_20363613221112432.PMC9274435.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40506725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Remission of a Primary, Recurrent Thoracic Ewing Sarcoma in a 74-year-old woman. 一名 74 岁女性的原发性复发性胸腔尤文肉瘤得到缓解。
IF 0.9 Q4 ONCOLOGY Pub Date : 2022-07-04 eCollection Date: 2022-01-01 DOI: 10.1177/20363613221110836
Robert M Tungate, Kristi Lara, Dakshesh Patel, Alexander Fedenko, James Hu

Ewing sarcoma is a primitive neuroectodermal tumor which seldom presents with primary disease in people over age 40 and outside of the appendicular or axial skeleton. We examine a case of primary thoracic Ewing Sarcoma diagnosed initially by CT-guided biopsy in a woman at the age of 74 years. The disease progressed after initial combined modality therapy consisting of neoadjuvant chemotherapy, surgical resection, and adjuvant radiation therapy and two additional courses of multiagent chemotherapy. After relapse of her disease, subsequent second- and third-line systemic agents which included chemotherapy and targeted agents were given with disease stabilization achieved now over 30 months from initial diagnosis. To our knowledge, this is the first report of a primary pulmonary Ewing sarcoma diagnosed in a patient greater than 70 years of age in whom multiple remissions have been achieved with tolerable toxicities.

尤文肉瘤是一种原始神经外胚层肿瘤,很少在 40 岁以上人群中出现原发性疾病,也很少发生在阑尾或轴向骨骼以外的部位。我们研究了一例原发性胸腔尤文肉瘤病例,患者是一名 74 岁的女性,最初通过 CT 引导活检确诊。在接受了包括新辅助化疗、手术切除、辅助放疗和两个额外的多药化疗疗程在内的初始联合治疗后,病情出现进展。疾病复发后,她接受了包括化疗和靶向药物在内的二线和三线系统药物治疗,现在距离最初诊断已超过 30 个月,病情趋于稳定。据我们所知,这是首例在 70 岁以上患者中诊断出原发性肺尤文肉瘤并在可耐受毒性反应的情况下实现多次缓解的报告。
{"title":"Remission of a Primary, Recurrent Thoracic Ewing Sarcoma in a 74-year-old woman.","authors":"Robert M Tungate, Kristi Lara, Dakshesh Patel, Alexander Fedenko, James Hu","doi":"10.1177/20363613221110836","DOIUrl":"10.1177/20363613221110836","url":null,"abstract":"<p><p>Ewing sarcoma is a primitive neuroectodermal tumor which seldom presents with primary disease in people over age 40 and outside of the appendicular or axial skeleton. We examine a case of primary thoracic Ewing Sarcoma diagnosed initially by CT-guided biopsy in a woman at the age of 74 years. The disease progressed after initial combined modality therapy consisting of neoadjuvant chemotherapy, surgical resection, and adjuvant radiation therapy and two additional courses of multiagent chemotherapy. After relapse of her disease, subsequent second- and third-line systemic agents which included chemotherapy and targeted agents were given with disease stabilization achieved now over 30 months from initial diagnosis. To our knowledge, this is the first report of a primary pulmonary Ewing sarcoma diagnosed in a patient greater than 70 years of age in whom multiple remissions have been achieved with tolerable toxicities.</p>","PeriodicalId":46078,"journal":{"name":"Rare Tumors","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2022-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/bc/de/10.1177_20363613221110836.PMC9260570.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40579243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Colonic schwannoma: A case of unusual presentation and outcome. 结肠神经鞘瘤:一个不寻常的表现和结果。
IF 0.9 Q4 Medicine Pub Date : 2022-06-24 eCollection Date: 2022-01-01 DOI: 10.1177/20363613221110837
Salsabil Nasri, Mohamed Hedi Mraidha, Mehdi Ben Abdelkrim, Sabri Youssef, Fehmi Hamila, Mohamed Amine Elghali

Background: Schwannomas are mesenchymal tumors arising from neural sheath cells and whose diagnosis is based on immunohistochemistery. The digestive and especially colonic location of this tumor is rare. Commonly described in elderly patient, their malignancy is unusual.

Case report: We report the case of a 23-year-old girl, with learning disability, operated in emergency for acute peritonitis. Peroperatively, we discovered a peritonitis secondary to a bulky perforated cecal tumor. We performed a right colectomy and an ileostomy. The posterior margin of the resection was macroscopically involved. The diagnosis of colonic schwannoma was confirmed with immunopathological examination of the surgical specimen. Surgical exploration 4 months later and morphological investigations during 2 years showed stability of the tumoral residue in the right iliac fossa. However, we noticed, on CT scanning control 2 years postoperatively, the appearance of a mesenteric recurrence. Exploratory laparotomy confirmed the unresectability of this mesenteric mass and showed the presence of multiple parietal nodules whose biopsies revealed their neurofibromatous nature. The 4 year follow-up of the patient didn't reveal any complication rather than need to right nephrostomy due to ureter compression by the primary tumoral residue.

Discussion: Colonic schwannoma is a rare disease, commonly described in uncomplicated stages. The learning disability of our patient had favorized the absence of declared symptoms and promoted the evolution of the cecal swhannoma until its perforation. This complication was not described before. Local recurrence has been also rarely reported in the literature. Association with neurofibroma may be hereditary in a context of neurofibromatosis or sporadic.

Conclusion: Colonic schwannoma may have polymorphic presentation mimicking malignant tumor in such cases. Not treated in time, it can lead to severe complications, such as tumoral perforation. Surgical resection remains the mainstay treatment. The slow evolutionary genius of schwannoma, even when incompletely resected by necessity, confirms its good prognosis.

背景:神经鞘瘤是起源于神经鞘细胞的间充质肿瘤,其诊断基于免疫组织化学。这种肿瘤很少发生在消化道,尤其是结肠。常见于老年患者,恶性肿瘤不常见。病例报告:我们报告一例23岁的女孩,有学习障碍,在急性腹膜炎急诊手术。手术中,我们发现一个腹膜炎继发于一个巨大的盲肠穿孔肿瘤。我们做了右结肠切除术和回肠造口术。切除后缘在宏观上受累。手术标本的免疫病理检查证实了结肠神经鞘瘤的诊断。4个月后手术探查和2年形态学检查显示右侧髂窝肿瘤残留稳定。然而,我们注意到,在术后2年的CT扫描对照中,出现肠系膜复发。剖腹探查证实了这个肠系膜肿块的不可切除性,并显示存在多个肠壁结节,活检显示其神经纤维瘤性质。患者4年随访未发现任何并发症,无需因原发肿瘤残留压迫输尿管而行右肾造口术。讨论:结肠神经鞘瘤是一种罕见的疾病,通常分期简单。本例患者的学习障碍倾向于没有明确的症状,并促进盲肠鱼鞘瘤的发展直至其穿孔。这种并发症以前没有被描述过。文献中也很少报道局部复发。与神经纤维瘤的关联在神经纤维瘤病或散发性的情况下可能是遗传性的。结论:结肠神经鞘瘤可能具有类似恶性肿瘤的多形态表现。如果不及时治疗,它会导致严重的并发症,如肿瘤穿孔。手术切除仍是主要的治疗方法。神经鞘瘤的缓慢进化天赋,即使在必要时不完全切除,也证实了其良好的预后。
{"title":"Colonic schwannoma: A case of unusual presentation and outcome.","authors":"Salsabil Nasri,&nbsp;Mohamed Hedi Mraidha,&nbsp;Mehdi Ben Abdelkrim,&nbsp;Sabri Youssef,&nbsp;Fehmi Hamila,&nbsp;Mohamed Amine Elghali","doi":"10.1177/20363613221110837","DOIUrl":"https://doi.org/10.1177/20363613221110837","url":null,"abstract":"<p><strong>Background: </strong>Schwannomas are mesenchymal tumors arising from neural sheath cells and whose diagnosis is based on immunohistochemistery. The digestive and especially colonic location of this tumor is rare. Commonly described in elderly patient, their malignancy is unusual.</p><p><strong>Case report: </strong>We report the case of a 23-year-old girl, with learning disability, operated in emergency for acute peritonitis. Peroperatively, we discovered a peritonitis secondary to a bulky perforated cecal tumor. We performed a right colectomy and an ileostomy. The posterior margin of the resection was macroscopically involved. The diagnosis of colonic schwannoma was confirmed with immunopathological examination of the surgical specimen. Surgical exploration 4 months later and morphological investigations during 2 years showed stability of the tumoral residue in the right iliac fossa. However, we noticed, on CT scanning control 2 years postoperatively, the appearance of a mesenteric recurrence. Exploratory laparotomy confirmed the unresectability of this mesenteric mass and showed the presence of multiple parietal nodules whose biopsies revealed their neurofibromatous nature. The 4 year follow-up of the patient didn't reveal any complication rather than need to right nephrostomy due to ureter compression by the primary tumoral residue.</p><p><strong>Discussion: </strong>Colonic schwannoma is a rare disease, commonly described in uncomplicated stages. The learning disability of our patient had favorized the absence of declared symptoms and promoted the evolution of the cecal swhannoma until its perforation. This complication was not described before. Local recurrence has been also rarely reported in the literature. Association with neurofibroma may be hereditary in a context of neurofibromatosis or sporadic.</p><p><strong>Conclusion: </strong>Colonic schwannoma may have polymorphic presentation mimicking malignant tumor in such cases. Not treated in time, it can lead to severe complications, such as tumoral perforation. Surgical resection remains the mainstay treatment. The slow evolutionary genius of schwannoma, even when incompletely resected by necessity, confirms its good prognosis.</p>","PeriodicalId":46078,"journal":{"name":"Rare Tumors","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2022-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7a/8c/10.1177_20363613221110837.PMC9237920.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40468230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Rare Tumors
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1